Skip to main navigation
Skip to Navigation Skip to Content
Mediclinic InternationalMediclinic International

 

  • Careers
  • Contact
  • Sustainable Development
  • Results Centre
  • News
  • Sustainable Development
  • Results Centre
  • News
Search
Hirslanden Home

Header Links Bottom

  • Sustainable Development
  • Results Centre
  • News

Sidebar Links - Middle

  • About Us
  • Clinical Services
  • Our Operations
  • Governance
  • Investor Relations
  • Media & News

Header Links Top

  • Careers
  • Contact
Hirslanden Home

Sidebar Right Links

About UsAbout Mediclinic InternationalStrategic OverviewPurpose, Vision and ValuesBoard of DirectorsExecutive Management
Clinical Services
Our OperationsOperating DivisionsHirslanden - SwitzerlandMediclinic Southern AfricaMediclinic Middle East
Our InvestmentsSpire Healthcare Group - UK
GovernanceGovernance OverviewBusiness Conduct & EthicsCorporate GovernanceRisk Management
Investor RelationsInvestor Overview
Share PerformanceShare ChartShare CalculatorShare Price Lookup
Results CentreResults and ReportsPresentations and Investor Days
Regulatory News
Offer for Mediclinic International plc
Investment Case
Investor CalendarUpcoming EventsPast Events
FinancialsFive-Year SummaryAnalystsDownloads
Shareholder CentreShareholder MeetingsDividendsRegistrarsCirculars & ProspectusesCombination of Mediclinic and AI NoorShareholder Privacy
Investor ContactInvestor RelationsCompany InformationInformation RequestsEmail AlertsCompany Advisors
Media & NewsMedia CentreNews & StoriesSocial MediaMedia Kit
Careers
Investor Relations

Financial Highlights

Five-Year SummaryAnalystsDownloads

Financial Highlights

Five-Year Summary

The Five-year summary is presented in pound sterling, rounded to the nearest million.

  IFRS 16 Pre-IFRS 16
INCOME STATEMENTS FY22
£'m
FY21
£'m
FY20
£'m
FY19
£'m
FY18
£'m
Revenue 3 233 2 995 3 083 2 932 2 876
Adjusted EBITDA 522 426 541 493 515
Operating (loss)/profit 280 209 (184) 81 (288)
Adjusted operating profit 311 221 327 330 370
Reported (loss)/earnings 151 68 (320) (151) (492)
Adjusted earnings 167 101 177 198 221

 

PER SHARE STATISTICS FY22
pence
FY21
pence
FY20
pence
FY19
pence
FY18
pence
Basic (loss)/earnings basis 20.5 9.2 (43.4) (20.5) (66.7)
Diluted (loss)/earnings basis 20.5 9.2 (43.4) (20.5) (66.7)
Basic adjusted earnings basis 22.6 13.7 24.0 26.9 30.0
Diluted adjusted earnings basis 22.6 13.7 24.0 26.9 30.0
Dividends declared per share 3.00 - 3.20 7.90 7.90

 

STATEMENTS OF FINANCIAL POSITION FY22
£'m
FY21
£'m
FY20
£'m
FY19
£'m
FY18
£'m
ASSETS          
Non-current assets 5 733 5 440 5 741 5 337 5 382
Current assets 1 474 1 232 1 213 1 091 961
Total assets 7 207 6 672 6 954 6 428 6 343
 
EQUITY          
Owners of the parent 3 107 2 849 2 890 3 151 3 286
Non-controlling interest 139 118 113 115 87
Total equity 3 246 2 967 3 003 3 266 3 373
 
LIABILITIES          
Non-current liabilities 3 138 3 021 3 182 2 576 2 445
Current liabilities 823 684 769 586 525
Total liabilities 3 961 3 705 3 951 3 162 2 970
Total equity and liabilities 7 207 6 672 6 954 6 428 6 343

 

STATEMENTS OF CASH FLOWS FY22 FY21 FY20 FY19 FY18
Operating cash flow (£'m) 663 330 589 451 466
Adjusted EBITDA cash conversion (%) 127 77 109 91 90

 

Page 80 in the ‘Financial review’ section in the Group Chief Financial Officer’s Report in the 2022 Annual Report sets out the Group’s use of adjusted non-IFRS financial measures. Non-IFRS measures, which include cash conversion, are further discussed, with reconciliations from the most comparable IFRS measure provided, on pages 81–86.

Website Notice Block

Email Alert Registration

Would you like to receive regular updates about Mediclinic International events and announcements? Then register for email alerts so we can send you all future updates directly.

Email Alerts

Scroll to Top
Mediclinic LogoHirslanden Home
Mediclinic International
  • About Mediclinic International
  • Our Operations
  • Governance
  • Investor Relations
  • Media & News
  • Careers
Contact
© Mediclinic International
Modern Slavery Statement
Terms of Use
Privacy Statement
Cookie Policy